Therapy of non-small cell lung cancer in stage IV

被引：1
|
作者：
Deppermann, Karl-Matthias [1 ]
Huber, Rudolf M.
Laack, Eckart
Reck, Martin
Serke, Monika
von Pawel, Joachim
机构：
[1] Ruppiner Klinikum GmbH, Klin Pneumol, Neuruppin, Germany
[2] Univ Munich, Med Klin Innenstadt, D-8000 Munich, Germany
[3] Univ Hamburg, Klinikum Eppendorf, Med Klin 2, Hamburg, Germany
[4] Krankenhaus Grosshansdorf, Zentrum Pneumol & Thoraxchirurg, D-2070 Grosshansdorf, Germany
[5] Helios Klinikum Emil von Behring, Klin Pneumol 2, Lungenklin Heckeshorn, Berlin, Germany
[6] Asklepios Fachkliniken Munchen Gauting, Schwerpunkt Onkol, Gauting, Germany
来源：
ONKOLOGIE | 2006年 / 29卷
关键词：
NSCLC; pharmacology; erlotinib; combination therapy; single agent therapy;
D O I：
10.1159/000094950
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 19
页数：5
相关论文
共 50 条
  • [41] CHEMOTHERAPEUTIC AND TARGETED AGENTS ON SURVIVAL IN STAGE IV NON-SMALL CELL LUNG CANCER
    Yu, Joanne L.
    Simmons, Christine
    Victor, Charles
    Han, Dolly
    Hogeveen, Sophie
    Leighl, Natasha
    Verma, Sunil
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S416 - S416
  • [42] Stage IV non-small cell lung cancer.: Duration of chemotherapy for locally advanced non small cell lung cancers
    Vergnenegre, A.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (05) : S72 - S77
  • [43] Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
    Chhatre, Sumedha
    Vachani, Anil
    Allison, Ron R.
    Jayadevappa, Ravishankar
    CANCERS, 2021, 13 (04) : 1 - 11
  • [44] Building a better therapy for stage IIIA non-small cell lung cancer
    Evans, TL
    Donahue, DM
    Mathisen, DJ
    Lynch, TJ
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 191 - +
  • [45] Non-small cell lung cancer - Diagnostics and stage-adapted therapy
    Heigener, David F.
    Reck, Martin
    Gatzemeier, Ulrich
    MEDIZINISCHE KLINIK, 2007, 102 (12) : 981 - 988
  • [46] Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
    Serke, Monika
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 135 - 144
  • [47] Adjuvant Therapy for Stage I and II Non-Small Cell Lung Cancer
    Naylor, Evan C.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 585 - +
  • [48] Combined modality therapy for stage III non-small cell lung cancer
    Stinchcombe, Thomas E.
    Fried, Daniel
    Morris, David E.
    Socinski, Mark A.
    ONCOLOGIST, 2006, 11 (07): : 809 - 823
  • [49] Proton therapy for stage I non-small cell lung cancer (NSCLC)
    Nihei, K
    Ogino, T
    Ishikura, S
    Nishimura, H
    Kawashima, M
    Arahira, S
    Onozawa, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S282 - S282
  • [50] Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer
    Watanabe, Shun-ichi
    Nakagawa, Kazuo
    Suzuki, Kenji
    Takamochi, Kazuya
    Ito, Hiroyuki
    Okami, Jiro
    Aokage, Keiju
    Saji, Hisashi
    Yoshioka, Hiroshige
    Zenke, Yoshitaka
    Aoki, Tadashi
    Tsutani, Yasuhiro
    Okada, Morihito
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (12) : 1112 - 1118
12345